NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 5 March 2009

RFCL-Mallinkrodt Baker deal off

RFCL has called off plans to acquire Mallinckrodt Baker. The two companies failed to agree a common valuatio, analysts expected the deal to be worth $325-350m.
Economic Times

No comments: